Citi says Diageo's earnings downgrade cycle is finally over

Citi said Diageo’s long run of earnings disappointments has ended, following the company’s capital markets day and Thursday’s results. The bank lifted its EPS forecasts for 2027 by 3% and for 2028 by 6%, signaling improved earnings outlook versus prior estimates.

Analysis

The key market implication is not the small EPS bump itself, but the possibility that DEO has moved from an execution-story discount to a credibility-repair story. In consumer staples, that shift matters because a restored growth path can lift the multiple faster than the earnings revision changes intrinsic value; a 1-2 turn rerating on forward EBITDA would outweigh the outer-year EPS uplift. If that read-through is right, the first beneficiaries are DEO equity holders and, secondarily, distributors and suppliers tied to a re-acceleration in replenishment rather than end-demand.

The competitive dynamic is more nuanced: a steadier DEO can take share in premium spirits without needing a full category recovery, especially if its pricing power proves better than peers' and inventory normalization is still in early innings. That creates pressure on names with narrower brand portfolios or more fragile volume trajectories, where any improvement in DEO makes relative underperformance easier to justify. The flip side is that any apparent recovery driven by channel restocking can fade quickly, leaving peers with the same underlying consumption problem but a better temporary headline.

Near term, the move is mostly a days-to-weeks sentiment event; over 1-3 months, the test is whether subsequent channel checks and the next print confirm that volume and mix improvements are real rather than accounting noise. Over 6-18 months, the question is whether DEO can convert stabilization into a durable margin and cash-flow compounding story. The thesis is falsified if organic growth re-slumps, margins fail to expand, or management is forced back into defensive guidance language on the next earnings cycle.

Consensus may still be underestimating how quickly a de-rated staple can rerate once the market believes the bad-news loop has ended. But it may also be overpricing the persistence of that improvement: in this category, one clean quarter can be enough to trigger upgrades, while one miss can undo them. The setup is attractive only if the next data points confirm that the forecast lift is being driven by end-demand, not just easier comps or a temporary inventory reset.

Key Decisions for Investors

• Long DEO on post-upgrade weakness; 1-3 month horizon. Thesis is multiple recovery more than EPS growth, with upside if the market starts pricing a credibility reset. Cut if the next update shows no organic growth or margin follow-through.
• Pair trade: long DEO / short BF.B over the next 1-2 quarters. DEO has more room for self-help rerating if execution stabilizes; BF.B is more vulnerable if investors rotate toward the cleaner turnaround story. Falsify if BF.B shows clearer volume inflection or DEO fails to hold relative strength.
• Use DEO as a call-spread expression only if the name sells off on the print. A 3-6 month call spread captures rerating potential with defined downside; the risk is paying for optimism before channel checks confirm it.
• Set an alert for the next organic sales and gross margin print rather than chasing the estimate upgrade. If either metric misses, the market will likely treat this as another false dawn and compress the multiple quickly.